Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5aef6c426a07b053aa061f946ce4f68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1976161f5bb7bbfd287d14162720cc69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
filingDate |
2016-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf2266bdf8f238e723f79b0924d312b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8b36c8aa49fc65ac052dd1424977cf1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_282930b2d8f10044610d66a0e2521a1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5c6d3de55b1705cf37e5a578336f687 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03f7b7d97329ca6dcac212f604164f8c |
publicationDate |
2022-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11231418-B2 |
titleOfInvention |
Processes for the diagnosis, prognosis and monitoring of the progression of chronic lymphoid leukaemia (CLL) and/or of systemic lupus erythematosus (SLE) using membrane STIM 1 |
abstract |
Some embodiments are directed to a process for the diagnosis of systemic lupus erythematosus (SLE) and/or of chronic lymphoid leukaemia (CLL) of a subject who may be suffering therefrom, comprising the in vitro detection of the expression of the fraction of the STIM1 protein located at the cell plasma membrane in a biological sample from human and mice. Some other embodiments are directed to a process for predicting the progression and/or monitoring the progression of CLL and/or of SLE, comprising the in vitro detection of the expression of the fraction of the STIM1 protein located at the cell plasma membrane. |
priorityDate |
2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |